Cerus (CERS)

Add to Watchlists
Create an Alert
4.10 -0.11  -2.61% NASDAQ Mar 27, 8:00PM BATS Real time Currency in USD
View Full Chart
CERS Price Chart
View All Events

CERS Events

Date Type Description
02/26/2015 16:15 EST Misc Cerus Corp Fourth Quarter Earnings Conference Call in 2014
02/26/2015 Earnings Cerus Corp Fourth Quarter Earnings in 2014 Release
11/04/2014 16:15 EST Misc Cerus Corp 3Q2014 Earning Conference Call
11/04/2014 Earnings Cerus Corp 3Q2014 Earning Result
07/31/2014 04:15 EDT Misc Cerus Corp 2Q2014 Earning Conference Call
07/31/2014 Earnings Cerus to Release Second Quarter 2014 Results
06/11/2014 Misc Annual General Meeting for Cerus Corp
05/01/2014 16:15 EDT Misc Cerus Corp 1Q2014 Earning Conference Call
05/01/2014 Earnings Cerus Corp 1Q2014 Earning Result
View All Performance Charts

CERS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cerus is down 16.67% over the last year vs S&P 500 Total Return up 13.76%, ISIS Pharmaceuticals up 50.34%, and Anthera Pharmaceuticals up 35.00%.

Get Quote for
Advertisement

Portfolio Strategies Featuring CERS

Did Cerus make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CERS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.cerus.com
  • IR Website: http://www.cerus.com/Investors/Investor-Overview/default.aspx
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: March 31, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: December 31, 2014
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.

CERS Excel Add-In Codes

  • Name: =YCI("CERS","name")
  • Description: =YCI("CERS","description")
  • Sector: =YCI("CERS","sector")
  • Industry: =YCI("CERS","industry")
  • Est. Current Fiscal Year End: =YCI("CERS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.